Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer

Author:

Sun Yongkun1,Du Feng2,Gao Ming3,Ji Qinghai4,Li Zhendong5,Zhang Yuan6,Guo Zhuming7,Wang Jun8,Chen Xiangjin9,Wang Jinwan1,Chi Yihebali1,Tang Pingzhang1

Affiliation:

1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute, Beijing, China.

3. Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

4. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

5. Department of Head and Neck Surgery, Liaoning Cancer Hospital and Institute, Shenyang, China.

6. Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Nanjing, China.

7. Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

8. Department of Thyroid and Breast Surgery, Gansu Provincial Cancer Hospital, Lanzhou, China.

9. Department of Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3